These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8460337)
1. Interferon alpha-2b treatment in an HIV-infected patient with hepatitis B virus induced nephrotic syndrome. Lidman C; Magnius L; Norder H; Weiland O Scand J Infect Dis; 1993; 25(1):133-5. PubMed ID: 8460337 [TBL] [Abstract][Full Text] [Related]
2. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome. Giboa N; Neigut D Pediatr Nephrol; 1993 Jun; 7(3):328-9. PubMed ID: 8518110 [No Abstract] [Full Text] [Related]
3. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon. Abbas NA; Pitt MA; Green AT; Solomon LR Nephrol Dial Transplant; 1999 May; 14(5):1272-5. PubMed ID: 10344378 [No Abstract] [Full Text] [Related]
5. Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection. Endo M; Ohi H; Fujita T; Ohsawa I; Kanmatsuse K; Yamaguchi Y Am J Nephrol; 1998; 18(5):439-43. PubMed ID: 9730572 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy]. Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290 [TBL] [Abstract][Full Text] [Related]
7. Membranous nephropathy related to hepatitis B virus in adults. Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605 [TBL] [Abstract][Full Text] [Related]
8. Remission of nephrotic syndrome of HBV-associated membranous glomerulopathy following treatment with interferon. Shapiro RJ; Steinbrecher UP; Magil A Am J Nephrol; 1995; 15(4):343-7. PubMed ID: 7573195 [TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078 [TBL] [Abstract][Full Text] [Related]
11. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response. Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310 [TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2b treatment in hepatitis B carriers. Effect on hepatitis B virus DNA levels in children infected with different genotypes. Sangfelt P; Norder H; Magnius LO; Alaeus A; Carlsson T; Reichard O Acta Paediatr; 1997 Feb; 86(2):135-7. PubMed ID: 9055880 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study. Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711 [TBL] [Abstract][Full Text] [Related]
14. The clinical course of hepatitis B virus-associated nephropathy. Gilbert RD; Wiggelinkhuizen J Pediatr Nephrol; 1994 Feb; 8(1):11-4. PubMed ID: 8142208 [TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937 [TBL] [Abstract][Full Text] [Related]
17. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478 [TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial. Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411 [TBL] [Abstract][Full Text] [Related]
19. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B. Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888 [TBL] [Abstract][Full Text] [Related]
20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]